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INTRODUCTION
Although heart transplantation has become a 
popular therapeutic modality in only the last 
decade, the technical groundwork started in the 
early 1900s and spanned more than 60 years, 
ultimately leading to the first successful clinical 
orthotopic allograft heart transplantation in 
1967(1-7). In addition to decades of work refining 
the operative technique, particularly over the last 
two decades, significant improvements in cardiac 
anesthesia and conduct of extracorporeal 
circulation, and better myocardial preservation 
techniques have all contributed to excellent 
operative outcome in heart transplantation. 
Today it is not unrealistic to expect a surgical 
mortality of well below 10%.
The following perspectives are based on the 
author’s personal experience encompassing 
close to 400 heart and lung transplant cases as 
Director of the Heart and Lung Transplantation 
Programs at the Oregon Health Sciences 
University, in Portland, Oregon, U.S.A.
Tim ing and Logistic of Donor- 
Recipient Operations
With the scarcity of donors and the tremendous 
demand of organs, organ procurement is
performed at distant donor sites and multiple 
teams are involved in the harvesting of multiple 
organs. Close attention to timing of recipient and 
donor operations in heart transplantation has 
never been more important. In order to achieve 
best functional results with the transplanted 
cardiac allograft, the total ischemic time should 
be kept to a minimum (8-9). Most centers have 
tried to keep this period to less than 4 hours, 
which translates into 3 hours of total transport 
time (approximately 2000 km of air travel) and an 
hour of implantation. For severely ill, 
hemodynamically unstable patients who 
otherwise might not survive, these time limits are 
generally extended. With an increasing number 
of recipients who have had previous open heart 
surgery (38% of cases at Oregon Health 
Sciences University), one has to allow additional 
time for meticulous cardiac dissection and have 
the recipient ready for cardiectomy as soon as 
the donor heart arrives. If one is to err in timing, 
it is best to have more time for the recipient in 
order not to have to rush the anesthesia and 
sternotomy in these patients because they are 
usually critically ill.
The Donor Cardiectomy
Since multiple teams are usually involved in the 
donor operation, the sequence of events should
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be collectively reviewed before starting the 
procedure and intraoperatively all moves should 
be made in close collaboration with other teams 
(10-11). It is appropriate that the cardiac surgeon 
take the leadership role in the intraoperative 
management of the donor and direct the fluid and 
drug therapy as necessary. In extreme 
hemodynamic instability refractory to therapeutic 
maneuvers, the heart would take priority over 
other organs and would be harvested after 
notifying other teams working on the liver, 
kidneys, and so on.
It is desirable to have good control of the donor’s 
hemodynamic status, which can be assisted by 
the use of large-bore intravenous lines, an 
arterial pressure monitor line and a central 
venous catheter. The cardiac surgery team may 
have to insert some of these lines before surgery 
in smaller hospitals with limited personnel and 
expertise in donor management.
The heart and other organs are approached 
through a long mid-line incision from the 
suprasternal notch to the symphysis pubis. The 
pericardium is incised and the mid-line incision is 
deepened in the area where the central tendon of 
the diaphragm fuses with its inferior surface. 
After pericardiotomy, the heart is carefully 
examined for evidence of contusion, coronary 
artery disease, valvular heart disease, or 
congenital anomaly. Sanguinous or 
serosanguinous effusion upon entry into the 
pericardial space might indicate myocardial 
trauma and injury.
Once the decision is made to use the heart, the 
ascending aorta and inferior vena cava are 
dissected free and controlled with tapes. The 
pulmonary artery is dissected free to its 
bifurcation. The superior vena cava is controlled 
with two heavy silk ties and dissected off the right 
pulmonary artery underneath it. Further 
dissection that might disturb the hemodynamic 
stability is not done and the circulation is 
supported while the abdominal organs are 
harvested. Just before harvesting of organs,
30.000 units of heparin are administered 
intravenously.
Proper myocardial preservation at the time of 
harvesting is obviously of utmost importance for 
good cardiac function in the recipient after
transplantation. Methods that are used on a daily 
basis in open heart procedures are used during 
cardiac harvest and include hypothermia and 
cardioplégie arrest of the heart. Selective cardiac 
hypothermia decreases oxygen consumption 
significantly and this is further enhanced by 
chemical cardioplegia, since 80% of myocardial 
oxygen consumption arises from mechanical 
work (12-13). For this purpose we prepare a cold 
crystalloid potassium cardioplegia solution 
(Table-I). This solution is kept at 3° to 4°C before 
administration.
Table I. Oregon Health Sciences University cardioplégie 
solution.








When harvesting is begun, the superior vena 
cava is doubly ligated and divided between 
ligatures, then the inferior vena cava is clamped 
right above the diaphragm. The heart is allowed 
to beat and empty for a few seconds, then the 
ascending aorta is cross-clamped at innominate 
artery take-off and the cardioplégie solution 
(1000 ml) is infused into the aortic root. The right 
inferior pulmonary vein and the inferior vena cava 
are transected immediately. During cardioplégie 
solution infusion, approximately 8 to 10 L of ice- 
cold physiologic solution is used for topical 
cooling and bathing the heart. The aorta is 
transected at the origin of the innominate artery 
and the main pulmonary artery at its bifurcation. 
All pulmonary veins are transected and the 
specimen is removed, rinsed in two basins of 
balanced electrolyte solution, and packed for 
transport. Before transplantation the donor heart 
is prepared for implantation by incising across 
and connecting the pulmonary veins and 
trimming the excess left atrial tissue.
The superior vena cava tie is reinforced with a 
circumferential 4-0 polypropylene suture, as well 
as the cardioplegia administration site in the 
ascending aorta. The interatrial septum Is 
inspected for presence of a patent foramen
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ovale; if present, this is fixed to prevent a 
significant right-to-left shunt that might result 
from temporary right ventricular dysfunction, poor 
compliance, and elevated right atrial pressures.
In the early 80’s, the author and his research 
team while at Thomas Jefferson University in 
Philadelphia, developed a chamber with a 
physiologic bath for a beating, auto-perfused 
heart-lung preparation. This “Jefferson Chamber” 
(cover photograph and Fig.I) was used to 
preserve the heart and both lungs for prolonged 
periods, with eventual successful transplantation 
in the laboratory setting. Though other centers in
the United States used similar preservation 
techniques and portable systems for donor 
preservation, all these were eventually 
abandoned due to being cumbersome and their 
complexity. Today, the donor heart is flushed out 
with cold physiologic solutions and then stored in 
same and transported in an ice-chest for 
simplicity.
The R e c ip ie n t O p e ra t io n
The patient comes into the operating room after 
having received all immunosuppressive drugs




and prophylactic antibiotics. If a distant donor 
procurement is to be done, the patient is not 
anesthetized until the donor heart is visualized 
and examined. Timing is more critical when the 
donor is in the transplant hospital or within close 
proximity. In these cases, particularly if the 
recipient has had prior cardiac surgery, the 
recipient is anesthetized, prepped, and draped, 
and all is ready to make the incision once the 
donor heart is inspected. The recipient should 
have one or two large-bore peripheral 
intravenous catheters, a radial artery catheter, 
and a left internal jugular vein catheter. Strict 
sterile technique must be observed at all times 
during catheter placement. In critically ill patients 
who have hemodynamic instability, or when 
weaning from cardiopulmonary bypass is 
expected to be difficult, a balloon-tipped, flow- 
directed pulmonary artery catheter should be 
placed. This catheter can be preserved during 
cardiectomy and then replaced just before 
completion of right atrial anastomosis, and before 
pulmonary artery anastomosis. Postoperatively 
in patients who have demonstrated instability, 
this catheter has been invaluable in assessment 
and management of hemodynamics.
The recipient’s heart is approached through a 
median sternotomy, the pericardial cavity is 
entered, and the pericardial edges are sutured to 
wound stockinettes. The aorta and superior and 
inferior vena cavae are circumferentially 
controlled with umbilical tapes. Tourniquettes are 
passed onto caval tapes. After systemic 
heparinization (3 mg/kg), the aorta is cannulated 
as distal as possible below the origin of the 
innominate artery. The superior and inferior vena 
cavae are cannulated through pursestrings 
placed on the right atrium close to the interatrial 
groove.
The recipient’s heart should not be excised until 
the donor heart arrives at the operating room. At 
that point cardiopulmonary bypass is started, 
superior and inferior caval tourniquets are 
tightened down, and the ascending aorta is 
cross-clamped after the heart empties in a few 
beats. The core temperature is usually taken 
down to 26°C.
The native heart is excised starting with an 
incision at the base of the right atrial appendage 
on the right lateral wall of the right atrium and
close to the atrioventricular junction. A small 
incision in the interatrial septum is made and a 
coronary suction catheter is introduced into the 
left side to decompress the left heart and 
facilitate the excision. The right atrial incision is 
carried downward and toward the left side and 
across the interatrial septum, making sure that 
the coronary sinus is left on the specimen side 
and that most of the interatrial septum is left 
behind. The aorta and the left pulmonary artery 
are divided close to the corresponding semilunar 
valves. The incision in the right atrium and the 
interatrial septum is carried on leftward to the 
dome of the left atrium and toward the base of 
the left atrial appendage. The left lateral wall of 
the left atrium is the last area that is incised, 
making sure that an adequate cuff of atrial tissue 
remains in front of the pulmonary veins for 
suturing without causing pulmonary venous 
obstruction.
The prepared donor heart is sutured starting with 
the left upper corner of the left atrial cuff and the 
base of the left atrial appendage of the donor 
heart. One arm of a 54-inch long double-armed
3-0 polypropylene suture is carried downward in 
an over-and-over fashion toward the 
diaphragmatic surface of the left atrium and then 
up to the mid-portion of the interatrial septum. 
The second arm of the suture is carried in a 
similar manner across the dome of the left atrium 
to the interatrial septum and this suture is 
secured on the outside of the left atrium.
The right free wall of the right atrium is incised 
obliquely starting at the lateral wall of the inferior 
vena cava up toward the base of the right atrial 
appendage. It is important to avoid the sinoatrial 
node and to leave enough of a cuff anteriorly to 
enable suturing without damage to the node or 
internodal pathways in the area of crista 
terminalis. A second 54-inch polypropylene 
suture is used to anastomose the donor right 
atrium to the right atrial cuff. This suture is started 
in the mid-portion of the interatrial septum and 
overlays the left atrial suture line to some degree. 
One arm is carried around clockwise to the right 
lateral wall of the right atrium and the second arm 
is carried around counterclockwise. This suture is 
secured on the lateral wall of the right atrium.
Although some advocated performing the aortic 
anastomosis next and then removing the cross­
2 3 6
Cardiac transplantation: operative techniques and early postoperative care
clamp, the approach at Oregon Health Sciences 
University has been to attach the donor and 
recipient pulmonary arteries in a quiet, bloodless 
field while the clamp Is still on. The anastomosis 
is started on the left lateral side of the arteries 
and carried around with a double-armed 4-0 
polypropylene suture. This suture is left untied 
anteriorly to use later during the cardiac 
resuscitation period.
The aortae are sutured with a double-armed 4-0 
polypropylene suture in a similar manner, starting 
at the left side of the aorta and moving in both 
directions. The suture is tied down anteriorly. 
During this anastomosis the patient is rewarmed 
to 37°C. A separate pursestring is placed at the 
highest point of the ascending aorta to introduce 
a large-bore needle to vent intracardiac air during 
ejection. Ventricular pacing electrodes are 
placed in the anterior wall of the ventricle. The 
heart is electrically fibrillated while the ascending 
aorta is vented and the aortic cross-clamp is 
removed. Caval tapes and tourniquets are 
removed; all intracardiac air is evacuated with 
aspiration of the right superior pulmonary vein 
and left ventricular apex. The heart Is defibrillated 
while the ascending aortic vent is still open. 
Varying amounts of time (usually 15-20 min.) are 
allowed for the donor heart to recover while still 
on bypass. Quite frequently a continuous 
intravenous infusion of isoproterenol (0.005-0.01 
pg/kg per min) is started to promote sinus rhythm 
and a heart rate of 100 to 110 beats/min. 
Infusions of dopamine, epinephrine, and 
nitroprusside are added as necessary in cases 
where right or left ventricular dysfunction or both 
are likely.
Once at 37°C, with normal sinus rhythm and 
good contractility, the patient is weaned off 
cardiopulmonary bypass. Protamine is 
administered to counter-effect the heparin. 
Decannulation and sternotomy closure are 
carried out in a routine manner. Two mediastinal 
drainage catheters and pleural catheters (if these 
cavities have been entered) are used. The usual 
cardiac implantation time is 45 to 50 min. and 
cardiopulmonary bypass time is 90 to 120 min.
Quite deary, during harvesting of the donor heart 
and other organs and preparation of the recipient 
and the actual transplantation operation, there 
are many little details that must be meticulously
attended to in order to secure successful 
outcome. Precise coordination, collaboration, 
and communication are never more important.
R e o p e ra tio n s
Most cardiac transplant services treat an 
increasing number of patients who have had prior 
cardiac operations due to coronary artery 
disease, valvular heart disease, or congenital 
heart defects.
If patients have been on sodium warfarin or 
heparin preoperatively, consideration should be 
given to using fresh frozen plasma in the pump 
prime solution.
Importance of meticulous attention to hemostasis 
at the time of sternotomy cannot be 
overemphasized. It is better to stop bleeding on 
the way in rather than on the way out. 
Electrocautery is used liberally throughout the 
procedure. Dissection is carried out to allow 
enough exposure of the right heart and the 
ascending aorta to cannulate and initiate 
cardiopulmonary pypass. In cases where an 
internal mammary graft is present, only minimal 
dissection is performed over the left heart. The 
left-sided dissection and separation of the aorta 
from the pulmonary artery can be performed 
once on bypass. The latter is easier once 
cardiectomy is done because the plane 
between the two vessels can be better 
identified. If one encounters multiple proximal 
vein graft anastomoses, the aorta is transected at 
the usual level and the proximal sites remaining 
on the aorta are oversewn. If there are dense 
adhesions in between the heart and pericardium 
or the adjacent lung due to felt pledgets, 
automatic defibrillator pads, electrodes, and so 
forth, thereby making dissection inordinately 
difficult, these could be left behind on the 
pericardium.
After discontinuation of cardiopulmonary bypass, 
one must be cautious in using blood and blood 
products. The pulmonary vascular resistance 
and right ventricular function are delicately 
balanced in most cases, and overzealous use of 
blood, fresh frozen plasma, or platelet infusions 
could tip this balance unfavorably. These should 
be given only if bleeding is truly excessive.
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E a rly  P o s to p e ra tiv e  C a re
H e m o d y n a m ic  M o n i t o r in g  a n d  S u p p o r t
The most common cause of hospital death early 
after cardiac transplantation is acute right 
ventricular failure or global biventricular 
dysfunction with low output syndrome. In cases 
of early postoperative left or biventricular 
dysfunction, the cause is likely to be myocardial 
preservation and usually resolves within 48 to 72 
hours. Conversely, patients with prior pulmonary 
hypertension and increased pulmonary vascular 
resistance are more likely postoperatively to 
develop right ventricular dysfunction. The 
therapeutic manipulations for these two 
scenarios may require vastly different 
approaches, which can be greatly facilitated by 
the use of a balloon-tipped, flow-directed 
pumonary artery catheter (now used routinely 
because of the higher risk patients and extended 
ischemic times). Ischemic injury results in 
myocardial edema, decreased compliance, and 
in more severe cases a reduction in systolic 
function. Both left and right ventricular filling 
pressures are elevated(14) and it is not 
infrequent that despite this, additional volume is 
required to optimize preload (sarcomere length) 
to improve cardiac output. If filling pressures are 
already excessive and poor cardiac output 
persists, a combination of inotropic support and 
vasodilator therapy is indicated (15-19). In most 
cases small doses of dopamine or dobutamine 
are adequate to maintain cardiac output. In 
patients with elevated systemic vascular 
resistance, small doses of sodium nitroprusside 
can be added (Table-ll).
In patients with acute right ventricular dysfunction 
secondary to pulmonary hypertension, the state 
of the heart is similar to that seen with acute right 
ventricular infarction. The right ventricle is dilated
T a b le  II. Intravenous agents used in the immediate 
postoperative period.
Adrenergic agents A-Effect B-Effect
Dobutamine (2-30 mg/kg/min) + ++++
Dopamine (2-30 mg/kg/min) ++ + + +
Epinephrine (0.025-0.25 mg/kg/min) +++ + + +
Isoproterenol (0.005-0.08 mg/kg/min) - + + + +
Vasodilators Venous Arterial
Nitroglycerin (0.3-6 mg/kg/min) + + + +
Nitroprusside (0.3-8 mg/kg/min) + + + + +
with impaired contractility, right ventricular output 
is inadequate to fill the left ventricle, and 
hypotension ensues(20). In contrast with right 
ventricular infarction, the pulmonary vasculature 
is not normal and volume expansion results in 
additional distension of the right ventricle (which 
likely has some degree of preservation injury), 
and further deterioration of hemodynamics. In 
this case, the primary therapy is inotropic 
support. If blood pressure can be maintained, 
systemic vasodilators may be of some benefit for 
their effects on the pulmonary vasculature. In 
addition, some groups have used prostaglandin 
E infusions in this circumstance for more 
selective pulmonary vasodilation(21).
Isoproterenol, a direct-acting beta agonist, is a 
commonly used drug. It increases the heart rate, 
causes peripheral vasodilation, and augments 
the cardiac output substantially. It is not unusual 
to continue an infusion of isoproterenol for 2 to 4 
days postoperatively. In cases where heart rate 
is refractory to pharmacologic maneuvers, 
epicardial atrial and ventricular pacing is used to 
optimize heart rate.
When pharmacologic measures are inadequate 
in dealing with the low output state, a means of 
mechanical circulatory assist becomes 
necessary. The intraaortic balloon pump (IABP) 
is often extremely effective when the cardiac 
index is 1.0 to 1.8 L/m2 and is secondary to 
biventricular dysfunction. IABP reduces both left 
ventricular afterload and preload with eventual 
reduction in myocardial oxygen demand. It 
augments the coronary blood flow by 30% to 
35% by increasing diastolic pressure and 
improvement in zonal myocardial perfusion. It 
produces an average increase in cardiac output 
of 20% to 25% (22-23). In extreme refractory 
cases of low cardiac output, one might have to 
resort to the use of unilateral or bilateral 
ventricular assist systems and/or 
retransplantation.
P r o t e c t i v e  I s o la t i o n  a n d  I n f e c t io n  C o n t r o l
Based on the initial Stanford experience, most 
centers used protective isolation to varying 
degrees. It is important to emphasize that there 
are currently no supporting data regarding the 
use of protective isolation in this patient 
population yet there are studies suggesting the 
lack of benefit for these procedures(24).
238
Cardiac transplantation: operative techniques and early postoperative care
Other infection control measures include the 
rapid removal of intravenous, intraarterial, and 
bladder catheters and early extubation to prevent 
catheter and pulmonary infections. Vigorous 
pulmonary toilet and early ambulation are also 
used to prevent pulmonary atelectasis. Frequent 
surveillance cultures and prophylactic antibiotics 
to cover common skin bacteria are used in most 
centers covering the time that catheters are in 
place. Finally, some centers use prophylactic 
trimethoprim sulfa and cytomegalovirus globulin 
for patients at risk.
I m m u n o s u p p r e s s io n
In general, after loading doses of 
immunosuppression are given preoperatively, it 
is the author’s preference that all 
immunosuppression is administered by 
intravenous route in the first 48 to 72 hours to 
ensure adequate bioavailability. By administering 
cyclosporine (2.5-3.0 mg/kg) by continuous 
infusion over 24 hours, therapeutic levels are 
achieved rapidly and fluctuations are minimal 
during this time period. No evidence of excessive 
renal toxicity has been noted using this protocol. 
Most transplant centers, however, administer 
cyclosporine via the nasogastric tube 
immediately postoperatively.
In patients who have moderate or severe renal 
insufficiency in the immediate or early 
postoperative period, cyclosporine can be 
avoided by using the monoclonal antibody to 
CD3, OKT3. Cyclosporine is then instituted on 
postoperative day 11.
M is c e l la n e o u s  M e d ic a l  C a re
Ventilator support with a volume-cycled 
mechanical respirator is provided for 12 to 24 
hours with early extubation if possible. With 
careful monitoring of fluid status and arterial 
oxygenation, most patients can be weaned from 
the respirator within 24 hours of the transplant 
operation. After cardiac transplantation patients 
usually require 3 to 4 days in the intensive care 
unit, another week to 10 days on the hospital 
ward, and are usually ready for hospital 
discharge by postoperative day 12 to 14.
Most patients undergoing cardiac transplantation 
have intravascular as well as interstitial volume 
expansion. In addition, patients often receive 
fluid and blood products intraoperatively. As the 
peripheral vasodilatory effects of anesthesia
wear off, to a variable degree, volume is shunted 
centrally, raising cardiac filling pressures. The 
maintenance of adequate urine output to 
compensate for excess volume is therefore 
required but can be further complicated by the 
renal vasoconstrictive properties of 
cyclosporine(25). In patients refractory to large 
doses of intravenous furosemide, intravenous 
ethacrinic acid in modest doses (50-100 mg) may 
be effective in the early postoperative period. 
Following daily weights is extremely imporant in 
deciding on the degree of diuresis.
R e h a b i l i t a t io n  a n d  P a t ie n t  E d u c a t io n
All patients undergoing cardiac transplantation, 
by the nature of their underlying disease, have 
been sedentary and have suffered severe 
physical deconditioning. Most centers are 
therefore aggressive in instituting physical 
therapy early postcardiac transplantation in an 
attempt to begin to reverse the deconditioning 
process. It is not unusual for patients to be 
ambulating while still in the intensive care setting, 
and riding a stationary bicycle under supervision 
4 to 5 days after the transplant operation. 
Physical therapy is continued for several weeks 
after transplantation.
Finally, patient education is instituted as soon as 
possible while patients are recovering from the 
operation. No patient is allowed to be discharged 
without first demonstrating a working 
understanding of cardiac transplant physiology 
(as it relates to exercise and daily activities), 
rejection and infection surveillance, and a 
complete understanding of the patient’s 
medication dosages, schedules, and side effects.
C o n c lu s io n s
Over a period of two decades, significant 
advances have been made in all aspects of 
cardiac transplantation, including better 
stabilization of transplant candidates in heart 
failure, advances in immunosuppression 
manipulation, and anesthesia in patients with 
severely compromised circulation. Refinement in 
operative techniques and better myocardial 
preservation methods have enabled rapid 
recovery of the transplanted heart and excellent 
graft function in most cases in the immediate 
postoperative period. With continued 
improvement in postoperative care and medical 
management of early graft dysfunction, hospital
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mortality after cardiac transplantation has 
continued to decline and approaches levels 
enjoyed by routine cardiovascular surgery.
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